IRIDEX (IRIX)
(Delayed Data from NSDQ)
$1.26 USD
-0.05 (-3.46%)
Updated Aug 7, 2025 12:16 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IRIX 1.26 -0.05(-3.46%)
Will IRIX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IRIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRIX
RMTI Stock Rises 138% in Q3: What Should You Do Ahead of Earnings?
Rockwell Medical on Expansion Spree: Should You Buy the Stock Now?
IRIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
Other News for IRIX
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025 | IRIX Stock News
12 Health Care Stocks Moving In Thursday's After-Market Session
Iridex (IRIX) Initiates DAME Trial for Diabetic Macular Edema Treatment | IRIX Stock News
Iridex announces first patient enrolled in investigator-led study of MicroPulse